Statins before Coronary Catheterization Linked with Reduced Risk of Contrast-Induced AKI

Among nearly 5000 patients who underwent coronary catheterization, the incidence of contrast-induced AKI was 3.91% in those who received a statin prior to the procedure, and 6.98% in those who did not. Overall, statin users had a 46% decreased risk of contrast-induced AKI compared to nonusers. Statin use was also associated with a 33% decreased risk of contrast-induced AKI among patients with eGFR <60 mL/min/1.73 m² and a 60% decreased risk among in patients with GFR ≥60. The findings, which pertain to data from 8 randomized controlled trials, are published in the American Journal of Cardiology.